[{"id":"13e8f40a-eabc-496f-b709-6fddc7d25c5e","acronym":"","url":"https://clinicaltrials.gov/study/NCT03432156","created_at":"2021-01-18T16:55:45.604Z","updated_at":"2024-07-02T16:37:04.547Z","phase":"Phase 2","brief_title":"Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)","source_id_and_acronym":"NCT03432156","lead_sponsor":"Beijing Friendship Hospital","biomarkers":" CEACAM5 • MUC16 • KRT19","pipe":"","alterations":" ","tags":["CEACAM5 • MUC16 • KRT19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e autologous Tcm cellular immunotherapy"],"overall_status":"Unknown status","enrollment":" Enrollment 68","initiation":"Initiation: 04/03/2018","start_date":" 04/03/2018","primary_txt":" Primary completion: 12/01/2019","primary_completion_date":" 12/01/2019","study_txt":" Completion: 12/01/2020","study_completion_date":" 12/01/2020","last_update_posted":"2018-12-19"}]